Nuwellis Secures New U.S. Patent, Strengthening Its Position as a Leader in Fluid Management Innovation
WHAT
WHERE
WHEN
WHY
Nuwellis, Inc.
Issuance of U.S. Patent No. 12,357,734
United States Patent and Trademark Office
July 15, 2025
To protect innovations in blood filtering system design and methods that support safe and precise fluid removal during ultrafiltration therapy.MINNEAPOLIS, July 15, 2025 (GLOBE NEWSWIRE) -- Nuwellis, Inc. (Nasdaq: NUWE), a medical technology company focused on fluid management solutions, today announced the issuance by the U.S Patent and Trademark Office of U.S. Patent No. 12,357,734, titled 'Extracorporeal Blood Filtering Machine and Methods.' The patent was officially granted on July 15, 2025, further strengthening the company's growing intellectual property portfolio.
The patent covers methods for improving the accuracy of fluid balance calculations by incorporating the density of replacement fluids and effluent—a known source of error in continuous renal replacement therapy (CRRT) systems that use weight-based measurements. While most systems assume a default fluid density of 1 g/mL, actual fluid densities vary. This discrepancy, if uncorrected, can lead to clinically relevant fluid balance errors. The patented approach enables CRRT systems to account for density—via user input, machine measurement, or derived data—resulting in more accurate volumetric flow tracking.
The patent joins Nuwellis' robust and growing portfolio, of pending U.S. patents related to its proprietary system and methods.
'Expanding our intellectual property portfolio is a key part of our strategy,' said John Erb, Chief Executive Officer of Nuwellis. 'Each new patent reinforces our commitment to building long-term value through innovation that supports patients, clinicians, and our future growth.'
This addition reflects Nuwellis' investment in protecting advancements in extracorporeal fluid management and reinforces its position in the evolving field of fluid management therapies.
For more information, visit www.nuwellis.com.
About Nuwellis Nuwellis, Inc. (Nasdaq: NUWE) is a medical device company dedicated to transforming the lives of patients suffering from fluid overload through science, collaboration, and innovation. The company is focused on commercializing the Aquadex SmartFlow® system for ultrafiltration therapy. Nuwellis is headquartered in Minneapolis, with a wholly owned subsidiary in Ireland. For more information visit www.nuwellis.com or visit us on LinkedIn or X, formerly known as Twitter.
About the Aquadex SmartFlow® System The Aquadex SmartFlow system delivers clinically proven therapy using a simple, flexible and smart method of removing excess fluid from patients suffering from hypervolemia (fluid overload). The Aquadex SmartFlow system is indicated for temporary (up to 8 hours) or extended (longer than 8 hours in patients who require hospitalization) use in adult and pediatric patients weighing 20 kg or more whose fluid overload is unresponsive to medical management, including diuretics. All treatments must be administered by a health care provider, within an outpatient or inpatient clinical setting, under physician prescription, both having received training in extracorporeal therapies.
Forward-Looking Statements Certain statements in this release may be considered forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, including without limitation, statements regarding the new market opportunities and anticipated growth in 2025 and beyond. Forward-looking statements are predictions, projections and other statements about future events that are based on current expectations and assumptions and, as a result, are subject to risks and uncertainties. Many factors could cause actual future events to differ materially from the forward-looking statements in this release, including, without limitation, those risks associated with our ability to execute on our commercialization strategy, the possibility that we may be unable to raise sufficient funds necessary for our anticipated operations, our post-market clinical data collection activities, benefits of our products to patients, our expectations with respect to product development and commercialization efforts, our ability to increase market and physician acceptance of our products, potentially competitive product offerings, intellectual property protection, our ability to integrate acquired businesses, our expectations regarding anticipated synergies with and benefits from acquired businesses, and other risks and uncertainties described in our filings with the SEC. Forward-looking statements speak only as of the date when made. Nuwellis does not assume any obligation to publicly update or revise any forward-looking statements, whether due to new information, future events or otherwise.
For further information, please contact:
Investor Relations: Robert ScottChief Financial Officerir@nuwellis.com
Media Contact: Leah McMullenDirector of CommunicationsLeah.mcmullen@nuwellis.comSign in to access your portfolio
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
San Francisco Chronicle
5 minutes ago
- San Francisco Chronicle
Fluent: Q2 Earnings Snapshot
NEW YORK (AP) — NEW YORK (AP) — Fluent, Inc. (FLNT) on Tuesday reported a loss of $7.2 million in its second quarter. The New York-based company said it had a loss of 30 cents per share. Losses, adjusted for one-time gains and costs, were 24 cents per share. The data and analytics company posted revenue of $44.7 million in the period. _____
NBC News
6 minutes ago
- NBC News
Nasdaq tumbles as Jackson Hole jitters hit tech stocks
The Nasdaq and S&P 500 slid on Tuesday driven by tech stocks, as investors gear up for what Federal Reserve chair Jerome Powell will say about the path of interest rates at a key conference later in the week. The Nasdaq fell as megacaps lost, after having rallied for much of the year. Nvidia fell 3.5%, the biggest drop in nearly four months. The key event this week is the Fed's annual symposium at Jackson Hole, Wyoming, from Aug. 21-23, where Powell's comments will be scrutinized for any clues on the central bank's outlook on the economy and monetary policy. 'It seems like folks are hedging a little going into Jackson Hole, thinking Powell might be more hawkish than markets currently appreciate,' said James Cox, managing partner at Harris Financial Group. Interest rate futures point to a total of two rate cuts this year worth 25 basis points each, with the first expected in September, according to data compiled by LSEG. Some market participants also expressed some concerns about AI-related stocks after OpenAI's CEO Sam Altman said they are in a bubble in an interview with 'The Verge' late last week. The Dow Jones Industrial Average rose 10.45 points, roughly flat, to 44,922.27, the S&P 500 lost 37.78 points, or 0.59%, to 6,411.37 and the Nasdaq Composite lost 314.82 points, or 1.46%, to 21,314.95. Steve Sosnick, chief strategist at Interactive Brokers, said some investors are taking some profits from tech stocks and rotating into other sectors. '(This move) spills into the broader market because of those stocks' weight in major indices,' he added. Still, six of the S&P 500 sectors rose. Real estate led the pack, up 1.8%, helped by better-than-expected housing data. On the other hand, technology and communications services lost over 1.9% and 1.2%, respectively. A Reuters poll showed on Tuesday that the S&P 500 will end 2025 just below current near-record levels, at 6,300 points, reflecting tempered optimism amid ongoing concerns over the economic impact of President Donald Trump's global tariffs and uncertainty surrounding Fed rate cuts. The blue-chip Dow briefly hit a record high on Tuesday, aided by a rise in Home Depot's shares after the retailer kept its annual forecasts intact. Home Depot rose 3.17% despite missing quarterly results estimates, while rival home-improvement chain Lowe's also gained 2.18%. Earnings from Lowe's and big-box retailers Walmart and Target later this week are now in focus as investors await more insight on the health of the American consumer. 'Consumers are still not really spending at full speed ahead, they're a little bit cautious,' said Peter Cardillo, chief market economist at Spartan Capital Securities. 'They're waiting to see the full results of the tariffs' impact on the upcoming holiday sales in a couple of months from now.' Intel jumped roughly 7% after the chipmaker got a $2 billion capital injection from Japan's SoftBank Group. Palo Alto Networks rose 3.06% after the cybersecurity company forecast fiscal 2026 revenue and profit above estimates. Medtronic lost 3.13%, after the company said it would add two new directors to its board after Elliott Investment Management took a large stake in the medical-device maker. Advancing issues outnumbered decliners by a 1.06-to-1 ratio on the NYSE. There were 205 new highs and 62 new lows on the NYSE. The S&P 500 posted 13 new 52-week highs and one new low while the Nasdaq Composite recorded 56 new highs and 88 new lows.
Miami Herald
9 minutes ago
- Miami Herald
Unusual Machines Secures $1.6 Million Order for Aura Cameras and HDO+ Goggles to Support U.S. Defense Supply Chain
ORLANDO, FLORIDA / ACCESS Newswire / August 19, 2025 / Unusual Machines, Inc. (NYSE American:UMAC), a provider of NDAA-compliant drone components, today announced a $1.6 million purchase of Fat Shark Aura cameras and HDO+ goggles placed by a domestic defense drone manufacturer. The components will be delivered through the U.S. defense supply chain, reinforcing Unusual Machines' role as a trusted supplier of compliant equipment. The Fat Shark Aura cameras are included in the Blue UAS Framework, confirming compliance with Department of Defense and NDAA standards. The HDO+ goggles offer high-clarity optics with the largest field of view of any analog FPV headset currently on the market, allowing operators to switch between 4:3 and 16:9 aspect ratios without narrowing the field of vision. Production will begin immediately, with initial deliveries scheduled for the end of September and the remainder completed by December. "This order represents a milestone for Unusual Machines and, importantly, reflects the trust our customers place in us to deliver large quantities of critical components," said Allan Evans, CEO of Unusual Machines. "By keeping cash reserves strong, scaling inventory ahead of demand, and strengthening our supply chain for larger volumes, we can execute quickly and reliably. This mindset allows us to accelerate delivery, ensure dependability, and expand manufacturing so more drone capability is built in the United States." Today's announcement reflects the growing scale of opportunities for Unusual Machines. While this order will ship from existing production lines, the upcoming U.S.-based manufacturing facility for HDO+ goggles underscores the company's long-term strategy to onshore even more production, keep pace with government demand, and deliver the capacity needed for future growth. Safe Harbor Statement This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. The words "believe," "may," "estimate," "continue," "anticipate," "intend," "should," "plan," "could," "target," "potential," "is likely," "will," "expect" and similar expressions, as they relate to us, are intended to identify forward-looking statements. These statements include: our expectation that we will deliver initial orders of the Aura cameras and HDO+ goggles by the end of September 2025 and the balance of the orders by December 2025, our ability to execute orders, our quickly and reliably, and our expectation that we will be successful leasing a new facility and expand our manufacturing footprint and build our headset production capabilities. The results expected by some or all of these forward-looking statements may not occur. Factors that affect our ability to achieve these results include our expectation that we will commence operations in our new Orlando manufacturing facility in September 2025 and close the Rotor Lab acquisition in the third quarter of 2025, the continued availability of commercial real estate near our Orlando, Florida facilities, the availability of a satisfactory labor pool, potential supply chain issues, the impact from tariffs including inflation, and the Risk Factors contained in our Form 10-Q, filed with the SEC on May 8, 2025, Prospectus Supplement filed with the Securities and Exchange Commission (the "SEC") on March 6, 2025 and in our Form 10-K for the year ended December 31, 2024. Factors or events that could cause our actual results to differ may emerge from time to time, and it is not possible for us to predict all of them. Any forward-looking statement made by us herein speaks only as of the date on which it is made. We undertake no obligation to update any forward-looking statement, whether as a result of new information, future developments or otherwise, except as may be required by law. About Unusual Machines Unusual Machines manufactures and sells drone components and drones across a diversified brand portfolio, which includes Fat Shark, the leader in FPV (first-person view) ultra-low latency video goggles for drone pilots. The Company also retails small, acrobatic FPV drones and equipment directly to consumers through the curated Rotor Riot ecommerce store. With a changing regulatory environment, Unusual Machines seeks to be a dominant Tier-1 parts supplier to the fast-growing multi-billion-dollar U.S. drone industry. According to the global drone accessories market is currently valued at $17.5 billion and is set to top $115 billion by 2032. For more information, please visit Investor Contact: CS Investor Relationsinvestors@ Media Contact: media@ SOURCE: Unusual Machines, Inc.
